medECUBE is a healthtech startup based in Gurugram, India, that runs a care coordination concierge service connecting patients, including international patients, with doctors and hospitals.

This Startup Deep Dive explains what medECUBE does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

medECUBE in Brief

• What it is: medECUBE is an Indian Healthcare concierge and care coordination company based in Gurugram.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• medECUBE runs an asset-less care coordination concierge that helps patients access doctors in major hospitals and clinics, including emergency care.
• Services include finding hospitals and doctors, second opinions, managing fragmented records and anticipating care steps.
• It serves domestic patients, international patients, corporates and practitioners, supported by a mobile app and back-end dashboards.
• Funding: $4 million across 1 round (reported).

medECUBE Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is medECUBE?

medECUBE operates in the Healthcare concierge and care coordination space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to medECUBE.

• medECUBE runs an asset-less care coordination concierge that helps patients access doctors in major hospitals and clinics, including emergency care.
• Services include finding hospitals and doctors, second opinions, managing fragmented records and anticipating care steps.
• It serves domestic patients, international patients, corporates and practitioners, supported by a mobile app and back-end dashboards.
• Company-stated: partners with over 150 hospitals and 100+ expert clinicians; holds NABH Medical Value Travel Facilitator certification (2018 profile).

The Origin Story of medECUBE

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Dilpreet Brar.
• Founded by Dr Dilpreet Brar, a physician who moved into hospital management.
• She spent about 10 years as an Executive Director at Max Healthcare, then was Regional Director at Fortis, where she took FMRI from inception to a $100 million business in three years (company-stated).
• She completed the General Management Programme at Harvard Business School in 2010.
• Her founding insight: clinical excellence is central to care, but coordination is incidental and causes most patient frustration and mishaps.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Healthcare concierge and care coordination sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 2015: company incorporated (director appointment October 2015).
• March 2016: Series A of about $4 million led by Artiman Ventures.
• 2017: coordinated care for about 9,000 patients in its first full year (company-stated).
• May 2018: profile reports over 10,000 patients, regional offices in 12 countries and outreach in 25 more (company-stated).
• Company-stated: collaboration with Tata Trusts on cancer centres and MoUs with international government bodies.

medECUBE Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• March 2016: Series A of about $4 million led by Artiman Ventures (reported).

How Does medECUBE Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Asset-less concierge: earns from coordinating care between patients and existing providers rather than owning hospitals.
• Product lines include GLOBE (international patients), DOTS (domestic care), CIRCLE (parents of NRIs) and LINK (remote care) (company-stated).
• Clients include individuals, corporates and practitioners.

The Numbers: medECUBE Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• FY21 revenue of INR 91 lakh, down 86% from INR 6.5 crore in FY20 (reported).
• Over 9,000 patients from over 27 countries serviced (company-stated).

Market Opportunity for medECUBE

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Medical value travel and patient navigation in India.
• Fragmented hospital care where coordination is a gap.

Technology and Product at medECUBE

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Mobile apps (Android and iOS) and back-end dashboards support a clinician-led, high-touch coordination model.

Team and Culture at medECUBE

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Founded and led by Dr Dilpreet Brar.
• Reported headcount of 7 to 9 employees, sources differ.

medECUBE Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for medECUBE

• Reported revenue fell sharply in FY21 versus FY20.
• The only reported funding round dates to 2016, and recent news coverage was not found.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.
• Data privacy risk: health records are sensitive, and breaches or misuse can bring legal and reputational harm.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

medECUBE Growth Outlook: What to Watch

• Founder's stated long-term goal (2018) was to reach 10 million lives; no recent plans found.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether medECUBE can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where medECUBE Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for medECUBE

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for medECUBE.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from medECUBE

Studying a company in the Healthcare concierge and care coordination space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about medECUBE.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate medECUBE as a Startup

• Customer clarity: Can medECUBE name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

medECUBE is part of India’s growing Healthcare concierge and care coordination ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

medECUBE FAQs: Frequently Asked Questions

What is medECUBE?

medECUBE is a healthtech startup based in Gurugram, India, that runs a care coordination concierge service connecting patients, including international patients, with doctors and hospitals. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded medECUBE?

medECUBE was founded by Dilpreet Brar, and the company reports a founding year of 2015.

How much funding has medECUBE raised?

$4 million across 1 round (reported). Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does medECUBE make money?

medECUBE earns revenue from its Healthcare concierge and care coordination products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of medECUBE?

Reported rivals include Medsurge, Meddo, Practo. See the competitor comparison above for how they differ.

What are the main risks for medECUBE?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Ketto — Ketto raised about $700K in 2015 from angel investors | Lenskart — Lenskart: from Rs 10 Cr loss to Rs 297 Cr profit, then IPO. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.